Is Nuvation Bio Inc. (NUVB) a Buy, Sell, or Hold?
NYSE : NUVB
Nuvation Bio Inc. — Analyst Ratings
$6.33 USD
-$0.37 (-5.52%)
- Volume
- 3.93M
- Average Volume
- 6.5M
- Market Capitalization
- $2.2B
- P/E Ratio
- -14.91
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $9.75
- Year Low
- $2.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.44
Analyst Consensus Summary
Consensus Rating
Sell
10 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-68.4%
vs Current Price
Price Target
$20.00
Average TargetPrice Target Range
Lowest Target
$19.00
-66.7% DOWNSIDE
Average Target
$20.00
Median Estimate
Highest Target
$21.00
-69.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 10
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Leonid Timashev | $12 | $6.01 | 2026-01-21 06:35 AM | 99.7% |
| UBS | Michael Yee | $10 | $8.49 | 2026-01-07 12:45 AM | 17.8% |
| H.C. Wainwright | Robert Burns | $10 | $8.04 | 2025-12-01 06:34 AM | 24.4% |